Nu Skin Enterprises (NYSE:NUS) will post its quarterly earnings results after the market closes on Tuesday, April 30th. Analysts expect Nu Skin Enterprises to post earnings of $0.72 per share for the quarter.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, February 13th. The company reported $1.05 EPS for the quarter, hitting the consensus estimate of $1.05. The firm had revenue of $683.29 million during the quarter, compared to analyst estimates of $676.76 million. Nu Skin Enterprises had a net margin of 4.55% and a return on equity of 25.98%. Nu Skin Enterprises’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.20 EPS. On average, analysts expect Nu Skin Enterprises to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
NYSE NUS opened at $48.45 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.82 and a quick ratio of 1.15. The company has a market cap of $2.76 billion, a P/E ratio of 13.76, a PEG ratio of 1.20 and a beta of 0.65. Nu Skin Enterprises has a 52 week low of $44.36 and a 52 week high of $88.68.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Recommended Story: Buyback For Investors Defined
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.